New drug TAK-188 aims to unleash immune system against Hard-to-Treat tumors
NCT ID NCT07205718
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 33 times
Summary
This study tests a new medicine called TAK-188 in adults with advanced solid tumors that have not improved with standard treatments. TAK-188 targets and removes certain cells inside tumors that weaken the immune system, potentially allowing the body to better fight the cancer. The trial will check safety, tolerability, and how well the drug works over up to one year of treatment, with follow-up for another year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Barbara Ann Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Florida Cancer Specialists - Lake Nona
RECRUITINGOrlando, Florida, 32827, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fox Chase Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19111-2497, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Johns Hopkins
NOT_YET_RECRUITINGBaltimore, Maryland, 21231, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
MD Anderson Cancer Center
NOT_YET_RECRUITINGHouston, Texas, 77030-4000, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
NEXT Dallas
RECRUITINGIrving, Texas, 75039, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
NEXT Virginia
RECRUITINGFairfax, Virginia, 22031, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Providence Cancer Institute, Franz Clinic
RECRUITINGPortland, Oregon, 97213-2933, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
SCRI Oncology
RECRUITINGNashville, Tennessee, 37203, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
START Midwest
RECRUITINGGrand Rapids, Michigan, 49546, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
START San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UCLA Health-Santa Monica Cancer Care (Cancer Care - Santa Monica)
RECRUITINGSanta Monica, California, 90404, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospitals Cleveland Medical Center
RECRUITINGCleveland, Ohio, 44106-1716, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Washington University
RECRUITINGSt Louis, Missouri, 63108, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Yale School of Medicine - Smilow Cancer Hospital - Center for Thoracic Cancers
RECRUITINGNew Haven, Connecticut, 06511, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.